Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month price target […]

Related Keywords

United States , Stifel Nicolaus , First Trust Advisors , Brinker Capital Investments , Proshare Advisors , Exelixis Inc , Nasdaq , Morgan Stanley , Get Free Report , Trust Advisors , Capital Investments , Share Advisors , Twinbeech Capital , Get Free , Exelixis Daily , Exelixis , Nasdaq Exel , Rexel , Medical , 30161q10 , Ratings , Consensus ,